๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Gene therapy for pancreatic cancer based on genetic characterization of the disease

โœ Scribed by Sunamura, Makoto ;Yatsuoka, Toshimasa ;Motoi, Fuyuhiko ;Duda, Dan G. ;Kimura, Mitsuhiro ;Abe, Tadayoshi ;Yokoyama, Tadaaki ;Inoue, Hiroko ;Oonuma, Masaru ;Takeda, Kazunori ;Matsuno, Seiki

Book ID
106179171
Publisher
Springer
Year
2002
Tongue
English
Weight
82 KB
Volume
9
Category
Article
ISSN
0944-1166

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Development of gene therapy-based strate
Development of gene therapy-based strategies for the treatment of eye diseases
โœ Piroska E. Rakoczy; Wei-Yong Shen; May Lai; Fabienne Rolling; Ian J. Constable ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 289 KB ๐Ÿ‘ 2 views

Gene therapy, which is the deliberate transfer of DNA for therapeutic purposes, can be defined as the in situ production of a therapeutical material within the diseased cells. The eye is an ideal target for gene therapy, as it is confined to a small space, separated by the retina-blood barrier from

Cytosine deaminase gene as a potential t
Cytosine deaminase gene as a potential tool for the genetic therapy of colorectal cancer
โœ Rowley, Simon; Lindauer, Marcus; Gebert, Johannes F.; Haberkorn, Uwe; Oberdorfer ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 632 KB

The bacterial enzyme cytosine deaminase (CD) catalyzes the conversion of 5-fluorocytosine (5-FC) to the lethal 5-fluorouracil (5-Fu) and so provides a useful system for selective killing of gene-modified mammalian tumor cells. Cloning of the CD gene from Escherichiu coli and expression in human tumo

The T classification of clinically local
The T classification of clinically localized prostate cancer. An appraisal based on disease outcome after radiation therapy
โœ Gunar K. Zagars; Fady B. Geara; Alan Pollack; Andrew C. Von Eschenbach ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 765 KB

Background. This study was performed to evaluate the use of the 1992 International Union Against Cancer (UICC)/American Joint Committee on Cancer (AJCC) T categories for localized prostate cancer treated with radiation therapy and to compare the prognostic power of this system with the Whitmore-Jewe